NanoSphere Health Sciences Inc.
NSHS
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.51% | -35.06% | 47.17% | -0.23% | -1.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.51% | -38.77% | 39.29% | -22.28% | -10.12% |
| Operating Income | -13.51% | 38.77% | -39.29% | 22.28% | 10.12% |
| Income Before Tax | 77.22% | 74.14% | -135.35% | 842.08% | -0.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 77.22% | 74.14% | -135.35% | 842.08% | -0.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.22% | 74.14% | -135.35% | 842.08% | -0.48% |
| EBIT | -13.51% | 38.77% | -39.29% | 22.28% | 10.12% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 78.05% | 74.58% | -137.50% | 849.06% | -2.50% |
| Normalized Basic EPS | 72.00% | 72.97% | -136.00% | -75.76% | 0.00% |
| EPS Diluted | 78.05% | 74.58% | -137.50% | 849.06% | -2.50% |
| Normalized Diluted EPS | 72.00% | 72.97% | -136.00% | -75.76% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |